Market Overview

Axillary Hyperhidrosis | A Drug Pipeline Analysis Report 2018 | Technavio


Technavio has announced their latest drug pipeline analysis report on axillary
. The report includes a detailed analysis of the
pipeline molecules under investigation within the defined data
collection period to treat axillary hyperhidrosis.

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for axillary hyperhidrosis, in ...

Technavio has published a new report on the drug development pipeline for axillary hyperhidrosis, including a detailed study of the pipeline molecules.(Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Axillary hyperhidrosis: Market overview

Axillary hyperhidrosis is a medical condition in which the body produces
excessive sweat in underarms. The individuals with axillary
hyperhidrosis sweat up to five times the amount that is necessary to
regulate the body temperature. Axillary hyperhidrosis can be genetic, so
if a family member suffers from the condition, the person is more likely
to inherit it.

According to a senior market research analyst at Technavio, "Axillary
hyperhidrosis also occurs by usage of caffeine in high quantum. This
condition tends to begin during puberty, but symptoms can appear up to
the age of 25 years, and can be treated by antiperspirants, lasers,
underarm surgery, and other techniques."

Axillary hyperhidrosis: Segmentation analysis

This pipeline analysis report segments the axillary hyperhidrosis market
based on RoA (topical), targets (muscarinic acetylcholine receptors
(mAChRs) and acetylcholine (Ach)) and geographical segmentation (US,
Germany, and Canada). It provides an in-depth analysis of the prominent
factors influencing the market, including drivers, opportunities,
trends, and industry-specific challenges.

Based on targets for drug development, 60% of the molecules that are
being investigated for the treatment of axillary hyperhidrosis are
muscarinic acetylcholine receptors.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!